HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Puerto Rico sales exceeded $30,000 following the brand's June debut in the country, a rate that tracks above the domestic average per door, Carson reports. Dermablend is available in eight Sears and two J.C. Penney doors in Puerto Rico, with a Macy's launch possible for spring 2001. The Puerto Rican entry was backed by a $50,000 advertising and public relations campaign heavily supported by Sears, Carson says. While the entire corrective cosmetics line is available in Puerto Rico, the shades were modified for the local market, the company notes. Carson also plans to move the brand into Brazil and Argentina (1"The Rose Sheet" June 14, 1999, p. 6)

You may also be interested in...

Carson Revitalizing Dermablend Brand Following Decision To Retain Business

Carson Products will support its Dermablend corrective cosmetics brand with an advertising campaign slated to break in September. The company will then back the brand with a "much larger" push in January 2000, Dermablend CEO Tim Hogan said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts